The global Breast AI-assisted Diagnosis market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

ReportPrime's newest research report, the “Breast AI-assisted Diagnosis Industry Forecast” looks at past sales and reviews total world Breast AI-assisted Diagnosis sales in 2022, providing a comprehensive analysis by region and market sector of projected Breast AI-assisted Diagnosis sales for 2023 through 2029. With Breast AI-assisted Diagnosis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Breast AI-assisted Diagnosis industry.

This Insight Report provides a comprehensive analysis of the global Breast AI-assisted Diagnosis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Breast AI-assisted Diagnosis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Breast AI-assisted Diagnosis market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Breast AI-assisted Diagnosis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Breast AI-assisted Diagnosis.

United States market for Breast AI-assisted Diagnosis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Breast AI-assisted Diagnosis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Breast AI-assisted Diagnosis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Breast AI-assisted Diagnosis players cover:

• Yizhun
• Sense Time
• United Imaging
• Huiying Medical
• BioMind

In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Breast AI-assisted Diagnosis market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Cloud-based
• On-Primes

Segmentation by Application:

• Hospital
• Clinic
• Imaging Center

This report also splits the market by region:

• Americas
  • United States
  • Canada
  • Mexico
  • Brazil
• APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
• Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration:

• Yizhun
• Sense Time
• United Imaging
• Huiying Medical
• BioMind
• Infervision
• Demetics Medical
• GE HealthCare
• Kheiron
• Hologic
• Densitas
• Lunit Inc.